833 related articles for article (PubMed ID: 11932281)
1. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
2. The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Sahin Y; Bayram F
Eur J Endocrinol; 1999 Jan; 140(1):56-61. PubMed ID: 10037253
[TBL] [Abstract][Full Text] [Related]
3. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
5. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome.
Ehrmann DA; Cavaghan MK; Imperial J; Sturis J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Feb; 82(2):524-30. PubMed ID: 9024248
[TBL] [Abstract][Full Text] [Related]
7. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
8. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
Nestler JE; Jakubowicz DJ
N Engl J Med; 1996 Aug; 335(9):617-23. PubMed ID: 8687515
[TBL] [Abstract][Full Text] [Related]
9. Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome.
Baillargeon JP; Iuorno MJ; Jakubowicz DJ; Apridonidze T; He N; Nestler JE
J Clin Endocrinol Metab; 2004 Jan; 89(1):242-9. PubMed ID: 14715857
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kouli C; Tsianateli T; Bergiele A
Eur J Endocrinol; 1998 Mar; 138(3):269-74. PubMed ID: 9539300
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
12. Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome.
Guido M; Romualdi D; Suriano R; Giuliani M; Costantini B; Apa R; Lanzone A
Hum Reprod; 2004 Mar; 19(3):534-9. PubMed ID: 14998947
[TBL] [Abstract][Full Text] [Related]
13. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
14. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
Arslanian SA; Lewy VD; Danadian K
J Clin Endocrinol Metab; 2001 Jan; 86(1):66-71. PubMed ID: 11231980
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
Ehrmann DA; Schneider DJ; Sobel BE; Cavaghan MK; Imperial J; Rosenfield RL; Polonsky KS
J Clin Endocrinol Metab; 1997 Jul; 82(7):2108-16. PubMed ID: 9215280
[TBL] [Abstract][Full Text] [Related]
16. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
[TBL] [Abstract][Full Text] [Related]
17. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
Romualdi D; De Cicco S; Tagliaferri V; Proto C; Lanzone A; Guido M
J Clin Endocrinol Metab; 2011 May; 96(5):E821-4. PubMed ID: 21307134
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
19. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
[TBL] [Abstract][Full Text] [Related]
20. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
Rittmaster RS; Deshwal N; Lehman L
J Clin Endocrinol Metab; 1993 May; 76(5):1295-300. PubMed ID: 8388405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]